Viszeral- und
Thoraxchirurgie

Dr. med. Christopher Soll

Oberarzt Klinik für Viszeral- und Thoraxchirurgie
Facharzt für Chirurgie
Schwerpunkt Viszeralchirurgie
EBSQ HPB Surgery

Hochschulausbildung
1994-2002Medizinstudium an der Georg-August-Universität Göttingen, Deutschland
2000Praktikum an der University of California, San Francisco, Department of Pathology
2001Praktikum University of Nottingham, City Hospital, Department of Oncology and Hematology, England
2001Praktikum in der Abteilung für Chirurgie, Regionalspital Sta Maria Visp, Schweiz
98-2002Max-Planck-Institut für biophysikalische Chemie Göttingen, Abteilung für Biochemie und Zellbiologie (Prof. Klaus Weber und Prof. Mary Osborn)
2002Promotion über “Antikörper- und Bindungsstudien über das humane NuMA-Protein”
Berufsausbildung
2002-2004Assistenzarzt, Chirurgie Regionalspital Sta Maria, Visp (Dr. Mauro Arigoni)
2005-2008Assistenzarzt, Universitätsspital Zürich, Abteilung für Viszeral- und Transplantationschirurgie (Prof. Pierre-Alain Clavien)
2006-2008Forschungsassistent (Research-Fellowship) in der hepatobiliären Arbeitsgruppe (Prof. P.-A. Clavien und Prof. Rolf Graf)
2009-2011Stellvertretender Oberarzt, Universitätsspital Zürich, Abteilung für Viszeral- und Transplantationschirurgie
2011FMH Chirurgie
2011-2012Stellvertretender Oberarzt (HPB-Fellow) für hepato-pankreatiko-biliäre Chirurgie, Universitätsspital Zürich
Seit 2013Oberarzt, Kantonsspital Winterthur, Klinik für Viszeral- und Thoraxchirurgie (PD Dr. Stefan Breitenstein)
2015EBSQ HPB Surgery
2017FMH Schwerpunkt Viszeralchirurgie
Forschungsstipendien und Preise
2008Krebsliga Zürich für das Projekt “Serotonin-mediated pathways in hepatocellular carcinomas”
2008Sassella Stiftung für das Projekt “Serotonin-mediated pathways in hepatocellular carcinomas
2009Sassella Stiftung für das Projekt “Serotonin-mediated pathways in hepatocellular carcinomas”
2009Best Research Award: Abteilung für Viszeral- und Tranplantationschirurgie, Universitätsspital Zürich
2010Best oral presentation Cancer, SGC Kongress Interlaken
Mitgliedschaften
  • FMH
  • Schweizer Gesellschaft für Chirurgie (SGC)
  • Schweizer Gesellschaft für Viszeralchirurgie (SGVC)
  • European Hepato-Pancreato-Biliary Association (EHPBA)

Originalarbeiten

1. Soll C, Hahnloser D, Dindo D, Clavien P-A, Hetzer F.
A novel approach for treatment of sacrococcygeal pilonidal sinus: less is more.
International journal of colorectal disease 2008;23(2): 177-180.
Impact Factor: 2.38 (2015)

2. Malz M, Weber A, Singer S, Riehmer V, Bissinger M, Riener M-O, Longerich T, Soll C, Vogel A, Angel P, Schirmacher P, Breuhahn K.
Overexpression of far upstream element binding proteins: a mechanism regulating proliferation and migration in liver cancer cells.
Hepatology (Baltimore, Md) 2009;50(4): 1130-1139.
Impact Factor: 11.71 (2015)

3. Riener M-O, Stenner F, Liewen H, Soll C, Breitenstein S, Pestalozzi BC, Samaras P, Probst-Hensch N, Hellerbrand C, Müllhaupt B, Clavien P-A, Bahra M, Neuhaus P, Wild PJ, Fritzsche FR, Moch H, Jochum W, Kristiansen G.
Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas.
Hepatology (Baltimore, Md) 2009;49(5): 1602-1609.
Impact Factor: 11.71 (2015)

4. Riener M-O, Wild PJ, Soll C, Knuth A, Jin B, Jungbluth A, Hellerbrand C, Clavien P-A, Moch H, Jochum W.
Frequent expression of the novel cancer testis antigen MAGE-C2/CT-10 in hepatocellular carcinoma.
International journal of cancer 2009;124(2): 352-357.
Impact Factor: 5.53 (2015)

5. Soll C, Hahnloser D, Frauenfelder T, Russi EW, Weder W, Kestenholz PB.
The postpneumonectomy syndrome: clinical presentation and treatment.
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 2009;35(2): 319-324.
Impact Factor: 2.80 (2015)

6. Riener M-O, Fritzsche FR, Soll C, Pestalozzi BC, Probst-Hensch N, Clavien P-A, Jochum W, Soltermann A, Moch H, Kristiansen G.
Expression of the extracellular matrix protein periostin in liver tumours and bile duct carcinomas.
Histopathology 2010;56(5): 600-606.
Impact Factor: 3.42 (2015)

7. Soll C, Jang JH, Riener M-O, Moritz W, Wild PJ, Graf R, Clavien P-A.
Serotonin promotes tumor growth in human hepatocellular cancer.
Hepatology (Baltimore, Md) 2010;51(4): 1244-1254.
Impact Factor: 11.71 (2015)

8. Brauckhoff A, Malz M, Tschaharganeh D, Malek N, Weber A, Riener M-O, Soll C, Samarin J, Bissinger M, Schmidt J, Longerich T, Ehemann V, Schirmacher P, Breuhahn K.
Nuclear expression of the ubiquitin ligase seven in absentia homolog (SIAH)-1 induces proliferation and migration of liver cancer cells.
Journal of hepatology 2011; 55(5):1049-57
Impact Factor: 10.59 (2015)

9. Soll C, Dindo D, Steinemann D, Hauffe T, Clavien P-A, Hahnloser D.
Sinusectomy for primary pilonidal sinus: Less is more.
Surgery 2011;150(5): 996-1001.
Impact Factor: 3.30 (2015)

10. Jang JH, Rickenbacher A, Humar B, Weber A, Raptis DA, Lehmann K, Stieger B, Moritz W, Soll C, Georgiev P, Fischer D, Laczko E, Graf R, Clavien P-A.
Serotonin protects mouse liver from cholestatic injury by decreasing bile salt pool after bile duct ligation.
Hepatology (Baltimore, Md) 2012;56(1): 209-18
Impact Factor: 11.71 (2015)

11. Soll C, Riener MO, Oberkofler CE, Hellerbrand C, Wild PJ, DeOliveira ML, Clavien P-A.
Expression of Serotonin Receptors in Human Hepatocellular Cancer.
Clinical Cancer Research 2012;18(21): 5902-5910.
Impact Factor: 8.74 (2015)
Comment: highlighted on the cover page of the november issue 2012

12. Wachter DL, Kristiansen G, Soll C, Hellerbrand C, Breuhahn K, Fritzsche F, Agaimy A, Hartmann A, Riener M-O.
Insulin-like growth factor II mRNA-binding protein 3 (IMP3) expression in hepatocellular carcinoma. A clinicopathological analysis with emphasis on diagnostic value.
Histopathology 2012;60(2): 278-286.
Impact Factor: 3.42 (2015)

13. Biraima M, Adamina M, Jost R, Breitenstein S, Soll C.
Long-term results of endoscopic balloon dilation for treatment of colorectal anastomotic stenosis.
Surg Endosc. 2016 Oct;30(10):4432-7
Impact Factor: 3.54 (2015)

14. Soll C, Wyss P, Gelpke H, Raptis DA, Breitenstein S.
Appendiceal stump closure using polymeric clips reduces intra-abdominal abscesses.
Langenbecks Arch Surg. 2016 Aug;401(5):661-6.
Impact Factor: 2.15 (2015)

15. International Surgical Outcomes Study group.
Global patient outcomes after elective surgery: prospective cohort study in 27 low-, middle- and high-income countries.
Br. J Anesth. 2016 Oct 31; 117(5):601-609
Impact Factor: 6.24 (2016)
Comment: Soll C is a collaborator of the study group

16. Schäfli-Thurnherr J, Biegger A, Soll C, Melcher GA.
Should nurses be allowed to perform the pre-operative surgical site marking instead of surgeons? A prospective feasibility study at a Swiss primary care teaching hospital.
Patient Saf Surg. 2017 Apr 4, 11:7
Impact Factor: n.a.

17. Kahan BC, Koulenti D, Arvaniti K, Beavis V, Campbell D, Chan M, Moreno R, Pearse RM;
International Surgical Outcomes Study (ISOS) group. Critical care admission following elective surgery was not associated with survival benefit: prospective analysis of data from 27 countries.
Intensive Care Med. 2017 Apr 25.
Impact Factor: 10.12 (2015)
Comment: Soll C is a collaborator of the ISOS group

18. Staerkle RF, Vuille-Dit-Bille RN, Fink L, Soll C, Villiger P.
Chronic pain and quality of life after inguinal hernia repair using the COMI-hernia score.
Langenbecks Arch Surg. 2017 Jun 13.
Impact Factor: 2.15 (2015)

Case Reports

1. Soll C, Müller MK, Wildi S, Clavien P-A, Weber M.
Reconstruction of the gastric passage by a side-to-side gastrogastrostomy after failed vertical-banded gastroplasty: a case report.
Journal of medical case reports 2008;2: 185.
Impact Factor: n.a.

2. Gerber PA, Soll C, Schmid C.
Rapidly vanishing hyperthyroidism.
QJM : monthly journal of the Association of Physicians 2013;106(1):69-70
Impact Factor: 2.82 (2015)

3. Beerle C, Soll C, Breitenstein S, Grieder F.
Spontaneous rupture of an intrahepatic aneurysm of the right hepatic artery caused by segmental arterial mediolysis.
BMJ Case Rep. 2016 Mar 18
Impact Factor: n.a.

4. Troller R, Soll C, Breitenstein S.
Glomus tumour of the stomach.
BMJ Case Rep. 2016 Jun 24
Impact Factor: n.a.

5. Bosshard A, Morf S, Jäggi M, Bindschädler P, Soll C, Maurer A, Ballmer PE.
Die Anziehungskraft des Essens.
Schweiz Med Forum 2017;16(42):899–901
Impact Factor: n.a.

6. Seidel AK, Pless M, Michel C, Soll C, Hochuli C, Gubler J.A
Rare Differential Diagnosis of an Adrenal Mass: A Case Report.
Case Rep Oncol. 2017 Nov 6;10(3):981-986.
Impact Factor: n.a.

Übersichtsarbeiten

1. Kapp T, Zadnikar M, Hahnloser D, Soll Ch, Hetzer FH.
Neues Therapiekonzept für den Pilonidal Sinus.
Praxis (Bern 1994) 2007;96(31-32):1171-6
Impact Factor: n.a.

2. Lesurtel M, Soll C, Graf R, Clavien P-A.
Role of serotonin in the hepato-gastroIntestinal tract: an old molecule for new perspectives.
Cellular and molecular life sciences: CMLS 2008;65(6): 940-952.
Impact Factor: 5.69 (2015)

3. Soll C, Dindo D, Hahnloser D.
Combined fissurectomy and botulinum toxin injection. A new therapeutic approach for chronic anal fissures.
Gastroentérologie clinique et biologique 2008;32(6-7): 667-670.
Impact Factor: 1.87 (2015)

4. Steinemann D, Dindo D, Soll C, Hahnloser D.
Pilonidalsinus und Analfistel.
Der Gastroenterologe 2010;5(4): 308-317
Impact Factor: n.a.

5. Lesurtel M, Soll C, Humar B, Clavien P-A.
Serotonin: A double-edged sword for the liver?
The Surgeon 2012;10(2):107-13
Impact Factor: 2.04 (2015)

6. Soll C, Schadde E, Petrowsky H. Clavien P-A.
Primäre und sekundäre Lebertumoren: Techniken der Leberresektion.
Schweiz Med Forum 2013;13(18):363–368
Impact Factor: n.a.

Buchbeiträge

1. Soll C, Clavien P-A. (2016) Left hemihepatectomy.
In: Atlas of upper gastrointestinal and hepato-pancreato-biliary surgery, 2nd Edition, Clavien P-A., Sarr MG, Fong Y, Miyazaki M (Eds), pp. 397-404, Springer

Weitere Publikationen

1. Soll C, Hahnloser D.
Invited comment for: Arthur JD et al. A pilot comparative study of fissurectomy/diltiazem and fissurectomy/botulinum toxin in the treatment of chronic fissure.
Techniques in Coloproctology 2008; 12(4): 331-6
Impact Factor: 2.32 (2015)
Type of publication: invited comment

2. Soll C, Clavien P-A.
Inhibition of mammalian target of rapamycin: the janus face of immunosuppression?
Hepatology (Baltimore, Md) 2010;51(4): 1113-1115.
Impact Factor: 11.71 (2015)
Type of publication: journal’s editorial

3. Soll C, Clavien P-A.
Inhibition of mammalian target of rapamycin: two goals with one shot?
Journal of hepatology 2011;54(1): 182-183.
Impact Factor: 10.59 (2015)
Type of publication: invited comment

4. Fisher OM, Oberkofler CE, Raptis DA, Soll C, Béchir M, Schiesser M, Graf R.
Pancreatic stone protein (PSP) and pancreatitis-associated protein (PAP): a protocol of a cohort study on the diagnostic efficacy and prognostic value of PSP and PAP as postoperative markers of septic complications in patients undergoing abdominal surgery (PSP study).
BMJ Open 2014;4(3): e004914.
Impact Factor: 2.56 (2015)
Type of publication: study protocol

5. Grochola LF, Soll C, Zehnder A, Wyss R, Herzog P, Breitenstein S.
Robot-assisted single-site compared with laparoscopic single-incision cholecystectomy for benign gallbladder disease: protocol for a randomized controlled trial.
BMC Surg. 2017 Feb 9;17(1):13.
Impact Factor: 1.47 (2015)
Type of publication: study protocol

  • Curriculum vitae
    Hochschulausbildung
    1994-2002Medizinstudium an der Georg-August-Universität Göttingen, Deutschland
    2000Praktikum an der University of California, San Francisco, Department of Pathology
    2001Praktikum University of Nottingham, City Hospital, Department of Oncology and Hematology, England
    2001Praktikum in der Abteilung für Chirurgie, Regionalspital Sta Maria Visp, Schweiz
    98-2002Max-Planck-Institut für biophysikalische Chemie Göttingen, Abteilung für Biochemie und Zellbiologie (Prof. Klaus Weber und Prof. Mary Osborn)
    2002Promotion über “Antikörper- und Bindungsstudien über das humane NuMA-Protein”
    Berufsausbildung
    2002-2004Assistenzarzt, Chirurgie Regionalspital Sta Maria, Visp (Dr. Mauro Arigoni)
    2005-2008Assistenzarzt, Universitätsspital Zürich, Abteilung für Viszeral- und Transplantationschirurgie (Prof. Pierre-Alain Clavien)
    2006-2008Forschungsassistent (Research-Fellowship) in der hepatobiliären Arbeitsgruppe (Prof. P.-A. Clavien und Prof. Rolf Graf)
    2009-2011Stellvertretender Oberarzt, Universitätsspital Zürich, Abteilung für Viszeral- und Transplantationschirurgie
    2011FMH Chirurgie
    2011-2012Stellvertretender Oberarzt (HPB-Fellow) für hepato-pankreatiko-biliäre Chirurgie, Universitätsspital Zürich
    Seit 2013Oberarzt, Kantonsspital Winterthur, Klinik für Viszeral- und Thoraxchirurgie (PD Dr. Stefan Breitenstein)
    2015EBSQ HPB Surgery
    2017FMH Schwerpunkt Viszeralchirurgie
    Forschungsstipendien und Preise
    2008Krebsliga Zürich für das Projekt “Serotonin-mediated pathways in hepatocellular carcinomas”
    2008Sassella Stiftung für das Projekt “Serotonin-mediated pathways in hepatocellular carcinomas
    2009Sassella Stiftung für das Projekt “Serotonin-mediated pathways in hepatocellular carcinomas”
    2009Best Research Award: Abteilung für Viszeral- und Tranplantationschirurgie, Universitätsspital Zürich
    2010Best oral presentation Cancer, SGC Kongress Interlaken
    Mitgliedschaften
    • FMH
    • Schweizer Gesellschaft für Chirurgie (SGC)
    • Schweizer Gesellschaft für Viszeralchirurgie (SGVC)
    • European Hepato-Pancreato-Biliary Association (EHPBA)
  • Publikationen

    Originalarbeiten

    1. Soll C, Hahnloser D, Dindo D, Clavien P-A, Hetzer F.
    A novel approach for treatment of sacrococcygeal pilonidal sinus: less is more.
    International journal of colorectal disease 2008;23(2): 177-180.
    Impact Factor: 2.38 (2015)

    2. Malz M, Weber A, Singer S, Riehmer V, Bissinger M, Riener M-O, Longerich T, Soll C, Vogel A, Angel P, Schirmacher P, Breuhahn K.
    Overexpression of far upstream element binding proteins: a mechanism regulating proliferation and migration in liver cancer cells.
    Hepatology (Baltimore, Md) 2009;50(4): 1130-1139.
    Impact Factor: 11.71 (2015)

    3. Riener M-O, Stenner F, Liewen H, Soll C, Breitenstein S, Pestalozzi BC, Samaras P, Probst-Hensch N, Hellerbrand C, Müllhaupt B, Clavien P-A, Bahra M, Neuhaus P, Wild PJ, Fritzsche FR, Moch H, Jochum W, Kristiansen G.
    Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas.
    Hepatology (Baltimore, Md) 2009;49(5): 1602-1609.
    Impact Factor: 11.71 (2015)

    4. Riener M-O, Wild PJ, Soll C, Knuth A, Jin B, Jungbluth A, Hellerbrand C, Clavien P-A, Moch H, Jochum W.
    Frequent expression of the novel cancer testis antigen MAGE-C2/CT-10 in hepatocellular carcinoma.
    International journal of cancer 2009;124(2): 352-357.
    Impact Factor: 5.53 (2015)

    5. Soll C, Hahnloser D, Frauenfelder T, Russi EW, Weder W, Kestenholz PB.
    The postpneumonectomy syndrome: clinical presentation and treatment.
    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 2009;35(2): 319-324.
    Impact Factor: 2.80 (2015)

    6. Riener M-O, Fritzsche FR, Soll C, Pestalozzi BC, Probst-Hensch N, Clavien P-A, Jochum W, Soltermann A, Moch H, Kristiansen G.
    Expression of the extracellular matrix protein periostin in liver tumours and bile duct carcinomas.
    Histopathology 2010;56(5): 600-606.
    Impact Factor: 3.42 (2015)

    7. Soll C, Jang JH, Riener M-O, Moritz W, Wild PJ, Graf R, Clavien P-A.
    Serotonin promotes tumor growth in human hepatocellular cancer.
    Hepatology (Baltimore, Md) 2010;51(4): 1244-1254.
    Impact Factor: 11.71 (2015)

    8. Brauckhoff A, Malz M, Tschaharganeh D, Malek N, Weber A, Riener M-O, Soll C, Samarin J, Bissinger M, Schmidt J, Longerich T, Ehemann V, Schirmacher P, Breuhahn K.
    Nuclear expression of the ubiquitin ligase seven in absentia homolog (SIAH)-1 induces proliferation and migration of liver cancer cells.
    Journal of hepatology 2011; 55(5):1049-57
    Impact Factor: 10.59 (2015)

    9. Soll C, Dindo D, Steinemann D, Hauffe T, Clavien P-A, Hahnloser D.
    Sinusectomy for primary pilonidal sinus: Less is more.
    Surgery 2011;150(5): 996-1001.
    Impact Factor: 3.30 (2015)

    10. Jang JH, Rickenbacher A, Humar B, Weber A, Raptis DA, Lehmann K, Stieger B, Moritz W, Soll C, Georgiev P, Fischer D, Laczko E, Graf R, Clavien P-A.
    Serotonin protects mouse liver from cholestatic injury by decreasing bile salt pool after bile duct ligation.
    Hepatology (Baltimore, Md) 2012;56(1): 209-18
    Impact Factor: 11.71 (2015)

    11. Soll C, Riener MO, Oberkofler CE, Hellerbrand C, Wild PJ, DeOliveira ML, Clavien P-A.
    Expression of Serotonin Receptors in Human Hepatocellular Cancer.
    Clinical Cancer Research 2012;18(21): 5902-5910.
    Impact Factor: 8.74 (2015)
    Comment: highlighted on the cover page of the november issue 2012

    12. Wachter DL, Kristiansen G, Soll C, Hellerbrand C, Breuhahn K, Fritzsche F, Agaimy A, Hartmann A, Riener M-O.
    Insulin-like growth factor II mRNA-binding protein 3 (IMP3) expression in hepatocellular carcinoma. A clinicopathological analysis with emphasis on diagnostic value.
    Histopathology 2012;60(2): 278-286.
    Impact Factor: 3.42 (2015)

    13. Biraima M, Adamina M, Jost R, Breitenstein S, Soll C.
    Long-term results of endoscopic balloon dilation for treatment of colorectal anastomotic stenosis.
    Surg Endosc. 2016 Oct;30(10):4432-7
    Impact Factor: 3.54 (2015)

    14. Soll C, Wyss P, Gelpke H, Raptis DA, Breitenstein S.
    Appendiceal stump closure using polymeric clips reduces intra-abdominal abscesses.
    Langenbecks Arch Surg. 2016 Aug;401(5):661-6.
    Impact Factor: 2.15 (2015)

    15. International Surgical Outcomes Study group.
    Global patient outcomes after elective surgery: prospective cohort study in 27 low-, middle- and high-income countries.
    Br. J Anesth. 2016 Oct 31; 117(5):601-609
    Impact Factor: 6.24 (2016)
    Comment: Soll C is a collaborator of the study group

    16. Schäfli-Thurnherr J, Biegger A, Soll C, Melcher GA.
    Should nurses be allowed to perform the pre-operative surgical site marking instead of surgeons? A prospective feasibility study at a Swiss primary care teaching hospital.
    Patient Saf Surg. 2017 Apr 4, 11:7
    Impact Factor: n.a.

    17. Kahan BC, Koulenti D, Arvaniti K, Beavis V, Campbell D, Chan M, Moreno R, Pearse RM;
    International Surgical Outcomes Study (ISOS) group. Critical care admission following elective surgery was not associated with survival benefit: prospective analysis of data from 27 countries.
    Intensive Care Med. 2017 Apr 25.
    Impact Factor: 10.12 (2015)
    Comment: Soll C is a collaborator of the ISOS group

    18. Staerkle RF, Vuille-Dit-Bille RN, Fink L, Soll C, Villiger P.
    Chronic pain and quality of life after inguinal hernia repair using the COMI-hernia score.
    Langenbecks Arch Surg. 2017 Jun 13.
    Impact Factor: 2.15 (2015)

    Case Reports

    1. Soll C, Müller MK, Wildi S, Clavien P-A, Weber M.
    Reconstruction of the gastric passage by a side-to-side gastrogastrostomy after failed vertical-banded gastroplasty: a case report.
    Journal of medical case reports 2008;2: 185.
    Impact Factor: n.a.

    2. Gerber PA, Soll C, Schmid C.
    Rapidly vanishing hyperthyroidism.
    QJM : monthly journal of the Association of Physicians 2013;106(1):69-70
    Impact Factor: 2.82 (2015)

    3. Beerle C, Soll C, Breitenstein S, Grieder F.
    Spontaneous rupture of an intrahepatic aneurysm of the right hepatic artery caused by segmental arterial mediolysis.
    BMJ Case Rep. 2016 Mar 18
    Impact Factor: n.a.

    4. Troller R, Soll C, Breitenstein S.
    Glomus tumour of the stomach.
    BMJ Case Rep. 2016 Jun 24
    Impact Factor: n.a.

    5. Bosshard A, Morf S, Jäggi M, Bindschädler P, Soll C, Maurer A, Ballmer PE.
    Die Anziehungskraft des Essens.
    Schweiz Med Forum 2017;16(42):899–901
    Impact Factor: n.a.

    6. Seidel AK, Pless M, Michel C, Soll C, Hochuli C, Gubler J.A
    Rare Differential Diagnosis of an Adrenal Mass: A Case Report.
    Case Rep Oncol. 2017 Nov 6;10(3):981-986.
    Impact Factor: n.a.

    Übersichtsarbeiten

    1. Kapp T, Zadnikar M, Hahnloser D, Soll Ch, Hetzer FH.
    Neues Therapiekonzept für den Pilonidal Sinus.
    Praxis (Bern 1994) 2007;96(31-32):1171-6
    Impact Factor: n.a.

    2. Lesurtel M, Soll C, Graf R, Clavien P-A.
    Role of serotonin in the hepato-gastroIntestinal tract: an old molecule for new perspectives.
    Cellular and molecular life sciences: CMLS 2008;65(6): 940-952.
    Impact Factor: 5.69 (2015)

    3. Soll C, Dindo D, Hahnloser D.
    Combined fissurectomy and botulinum toxin injection. A new therapeutic approach for chronic anal fissures.
    Gastroentérologie clinique et biologique 2008;32(6-7): 667-670.
    Impact Factor: 1.87 (2015)

    4. Steinemann D, Dindo D, Soll C, Hahnloser D.
    Pilonidalsinus und Analfistel.
    Der Gastroenterologe 2010;5(4): 308-317
    Impact Factor: n.a.

    5. Lesurtel M, Soll C, Humar B, Clavien P-A.
    Serotonin: A double-edged sword for the liver?
    The Surgeon 2012;10(2):107-13
    Impact Factor: 2.04 (2015)

    6. Soll C, Schadde E, Petrowsky H. Clavien P-A.
    Primäre und sekundäre Lebertumoren: Techniken der Leberresektion.
    Schweiz Med Forum 2013;13(18):363–368
    Impact Factor: n.a.

    Buchbeiträge

    1. Soll C, Clavien P-A. (2016) Left hemihepatectomy.
    In: Atlas of upper gastrointestinal and hepato-pancreato-biliary surgery, 2nd Edition, Clavien P-A., Sarr MG, Fong Y, Miyazaki M (Eds), pp. 397-404, Springer

    Weitere Publikationen

    1. Soll C, Hahnloser D.
    Invited comment for: Arthur JD et al. A pilot comparative study of fissurectomy/diltiazem and fissurectomy/botulinum toxin in the treatment of chronic fissure.
    Techniques in Coloproctology 2008; 12(4): 331-6
    Impact Factor: 2.32 (2015)
    Type of publication: invited comment

    2. Soll C, Clavien P-A.
    Inhibition of mammalian target of rapamycin: the janus face of immunosuppression?
    Hepatology (Baltimore, Md) 2010;51(4): 1113-1115.
    Impact Factor: 11.71 (2015)
    Type of publication: journal’s editorial

    3. Soll C, Clavien P-A.
    Inhibition of mammalian target of rapamycin: two goals with one shot?
    Journal of hepatology 2011;54(1): 182-183.
    Impact Factor: 10.59 (2015)
    Type of publication: invited comment

    4. Fisher OM, Oberkofler CE, Raptis DA, Soll C, Béchir M, Schiesser M, Graf R.
    Pancreatic stone protein (PSP) and pancreatitis-associated protein (PAP): a protocol of a cohort study on the diagnostic efficacy and prognostic value of PSP and PAP as postoperative markers of septic complications in patients undergoing abdominal surgery (PSP study).
    BMJ Open 2014;4(3): e004914.
    Impact Factor: 2.56 (2015)
    Type of publication: study protocol

    5. Grochola LF, Soll C, Zehnder A, Wyss R, Herzog P, Breitenstein S.
    Robot-assisted single-site compared with laparoscopic single-incision cholecystectomy for benign gallbladder disease: protocol for a randomized controlled trial.
    BMC Surg. 2017 Feb 9;17(1):13.
    Impact Factor: 1.47 (2015)
    Type of publication: study protocol